Clinical Trials Directory

Trials / Sponsors / Cadila Pharnmaceuticals

Cadila Pharnmaceuticals

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
UnknownClinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
COVID-19
Phase 32020-06-30
UnknownClinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With
COVID-19
Phase 32020-06-30
CompletedA Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients
COVID-19
N/A2020-04-30
CompletedEffect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus
Uncontrolled Type 2 Diabetes Mellitus
Phase 32020-01-26
CompletedA Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Pati
Mild to Moderate Plaque Psoriasis
Phase 32018-10-03
CompletedStudy of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder
Bladder Cancer
Phase 12008-10-01
CompletedStudy of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder
Bladder Cancer
Phase 22008-08-28
CompletedA Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cance
Non Small Cell Lung Cancer
Phase 22008-06-01
TerminatedA Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer
Hormone Refractory Prostate Cancer
Phase 22007-11-01
TerminatedSafety Study of CADI-05 in Patients With Advanced Stage Melanoma
Stage III or Stage IV Melanoma
Phase 1 / Phase 22006-12-01
CompletedEfficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal F
Anemia
Phase 32006-12-01